# Semaglutide use in patients undergoing atrial fibrillation ablation and recurrent arrhythmia: A focused time-to-event meta-analysis.

> PubMed lists PMID 42217600 in Heart rhythm as Journal Article, with publication-date metadata of 2026-05-30 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-42217600-semaglutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-06-28
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-42217600-semaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-42217600-semaglutide-v1.json
- Content SHA-256: `99d1cf9d12a451a199ceb47ba0b74bd88b872bb8720908207f51a269a6a1d7c6`

## Claims and source pins

### Headline

Semaglutide use in patients undergoing atrial fibrillation ablation and recurrent arrhythmia: A focused time-to-event meta-analysis. ([`pubmed-observation-pmid-42217600-2026-06-28-63aa11a5b519`](#source-pubmed-observation-pmid-42217600-2026-06-28-63aa11a5b519))

### Summary

PubMed lists PMID 42217600 in Heart rhythm as Journal Article, with publication-date metadata of 2026-05-30 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-42217600-2026-06-28-63aa11a5b519`](#source-pubmed-observation-pmid-42217600-2026-06-28-63aa11a5b519))

### Paragraph 1

PubMed lists PMID 42217600 in Heart rhythm as Journal Article, with publication-date metadata of 2026-05-30 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-42217600-2026-06-28-63aa11a5b519`](#source-pubmed-observation-pmid-42217600-2026-06-28-63aa11a5b519))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-42217600-2026-06-28-63aa11a5b519`](#source-pubmed-observation-pmid-42217600-2026-06-28-63aa11a5b519))

## Sources

<a id="source-pubmed-observation-pmid-42217600-2026-06-28-63aa11a5b519"></a>
- **Semaglutide use in patients undergoing atrial fibrillation ablation and recurrent arrhythmia: A focused time-to-event meta-analysis. · retained source version 1:2026-06-28:current:63aa11a5b51915c66ee4a30b06f00c853f7fbe5bd63e23838da4515605785351** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/42217600/) (`pubmed-observation-pmid-42217600-2026-06-28-63aa11a5b519`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Semaglutide use in patients undergoing atrial fibrillation ablation and recurrent arrhythmia: A focused time-to-event meta-analysis." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-42217600-semaglutide-v1.json SHA-256: 99d1cf9d12a451a199ceb47ba0b74bd88b872bb8720908207f51a269a6a1d7c6.